Glomerular and tubular function in penal transplant patients treated with and without ciclosporin A

Nephron

Volumn 80, Issue 4, 1998, Pages 450-457

  Hansen, Jesper Melchior ^a   Fogh Andersen, Niels ^a   Leyssac, Paul Peter ^b   Strandgaard, Svend ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ciclosporin; Effective renal plasma flow; Glomerular filtration rate; Lithium clearance; Magnesium clearance; Renal transplant recipients; Sodium clearance; Urate clearance

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LITHIUM; MAGNESIUM ION; PREDNISONE; URATE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIURESIS; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; NEPHROTOXICITY; PRIORITY JOURNAL;

ADULT; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LITHIUM; MAGNESIUM; MALE; MIDDLE AGED; RENAL CIRCULATION; URIC ACID;

EID: 0031762592     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Curtis JJ, Luke RG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P: Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986;ii:477-479.
2. Hansen JM, Fogh-Andersen N, Christensen NJ, Strandgaard S: Cyclosporine-induced hypertension and decline in renal function in healthy volunteers. J Hypertens 1997;15:319-326.
3. Hansen JM, Christensen NJ, Fogh-Andersen N, Strandgaard S: Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients. Nephrol Dial Transplant 1996;11:340-346.
4. Hansen JM, Hoy CE, Strandgaard S: Fish oil and cyclosporin A-induced renal hypoperfusion in kidney-transplanted patients. Nephrol Dial Transplant 1995;10:1745-1750.
5. Racusen LC, Solez K: Cyclosporine nephrotoxicity. In Rev Exp Pathol 1988;30:107-157.
6. Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Hayry P: Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992;41:155-160.
7. Rodriguez F, Krayenbühl JC, Harrison WB, Forre O, Dijkmans BA, Tugwell P, Miescher PA, Mihatsch MJ: Renal biopsy findings and follow-up of renal function in rheumatoid arthritis patients treated with cyclosporin A: An update from the International Kidney Biopsy Registry. Arthritis Rheum 1996;39:1491-1498.
8. Palestine AG, Austin HA, Nussenblatt RB: Renal tubular function in cyclosporine-treated patients. Am J Med 1986;81:419-424.
9. Barton CH, Vaziri ND, Martin DC, Choi S, Alikhani S: Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med 1987;83:693-699.